Comparing the soluble urokinase-type plasminogen activator receptor (suPAR) levels between individuals with subjective cognitive decline and mild cognitive impairment

被引：0
|
作者：
Batun, G. Cetiner [1 ]
Gultekin, G. [1 ]
Yuruyen, M. [2 ]
Yavuzer, H. [3 ]
Armutcu, F. [4 ]
Emul, M. [1 ]
Kocabasoglu, N. [1 ]
机构：
[1] Istanbul Univ, Med Sch Cerrahpasa, Psychiat, Istanbul, Turkey
[2] Istanbul Univ, Med Sch Cerrahpasa, Dept Geriatr, Istanbul, Turkey
[3] Istanbul Univ, Med Sch Cerrahpasa, Geriatr, Istanbul, Turkey
[4] Istanbul Univ, Med Sch Cerrahpasa, Biochem, Istanbul, Turkey
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2016年 / 26卷
关键词：
CANCER;
D O I：
10.1016/S0924-977X(16)31734-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.5.a.004
引用
收藏
页码：S637 / S638
页数：2
相关论文
共 50 条
  • [1] Increased Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in Plasma of Suicide Attempters
    Ventorp, Filip
    Gustafsson, Anna
    Traskman-Bendz, Lil
    Westrin, Asa
    Ljunggren, Lennart
    [J]. PLOS ONE, 2015, 10 (10):
  • [2] Comparing the nesfatin-1 levels between individuals with subjective cognitive decline and mild cognitive impairment
    Gultekin, G.
    Batun, G. C.
    Yuruyen, M.
    Yavuzer, H.
    Akcan, F. E.
    Armutcu, F.
    Tosun, M.
    Emul, M.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S203 - S204
  • [3] Comparing the alexithymia features between individuals with subjective cognitive decline and mild cognitive impairment
    Batun, G. Cetiner
    Gultekin, G.
    Yuruyen, M.
    Yavuzer, H.
    Akcan, F. Engin
    Emul, M.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S583 - S583
  • [4] Soluble urokinase-type plasminogen activator receptor (suPAR) and interleukin-6 levels in hyperemesis gravidarum
    Desdicioglu, Raziye
    Yildirim, Melahat
    Kocaoglu, Gulcan
    Cendek, Busra Demir
    Avcioglu, Gamze
    Tas, Emre Erdem
    Sengul, Ozlem
    Erel, Ozcan
    Yavuz, Ayse Filiz
    [J]. JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2018, 81 (09) : 825 - 829
  • [5] Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism
    Joyce, Jessica
    Cabanas, Noel
    Pisharody, Rohan
    Ouyang, Bichun
    Patel, Roshni
    Reiser, Jochen
    Hall, Deborah A.
    Witek, Natalie
    [J]. PARKINSONISM & RELATED DISORDERS, 2022, 101 : 39 - 42
  • [6] Soluble urokinase-type plasminogen activator receptor (SuPAR) in patients with Parkinson's disease
    Witek, N.
    Joyce, J.
    Hawkins, J.
    Liu, Y.
    Ouyang, B.
    Patel, R.
    Borgia, J.
    Reiser, J.
    Hall, D.
    [J]. MOVEMENT DISORDERS, 2021, 36 : S460 - S460
  • [7] Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia
    Guo, Hong
    Zhou, Lan-Xia
    Ma, Haizhen
    Liu, Bei
    Cheng, Juan
    Ma, Yun-Yun
    Zhao, Li
    [J]. ONCOLOGY LETTERS, 2017, 14 (01) : 383 - 389
  • [8] Soluble urokinase-type plasminogen activator receptor (suPAR) - a possible biomarker for bacteremia in sepsis
    Georgescu, Anca-Meda
    Szederjesi, Janos
    Voidazan, Septimiu
    Dobreanu, Minodora
    Copotoiu, Sanda Maria
    Hutanu, Adina
    Azamfirei, Leonard
    [J]. REVISTA ROMANA DE MEDICINA DE LABORATOR, 2015, 23 (01): : 59 - 73
  • [9] Serum soluble urokinase-type plasminogen activator receptor (suPAR) levels in male patients with acute exacerbation of schizophrenia
    Genc, A.
    Kalelioglu, T.
    Karamustafalioglu, N.
    Tasdemir, A.
    Genc, E. Sena
    Akkus, M.
    Emul, M. H.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S232 - S233
  • [10] Increased Serum Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in FSGS: A Meta-Analysis
    Lee, Jiwon M.
    Yang, Jae Won
    Kronbichler, Andreas
    Eisenhut, Michael
    Kim, Gaeun
    Lee, Keum Hwa
    Shin, Jae Il
    [J]. JOURNAL OF IMMUNOLOGY RESEARCH, 2019, 2019
12345